Boronic acid-mediated mucin/surface interactions of zwitterionic polymer brushes

Karla E Cureno Hernandez1, Jeonghun Lee1, Sunghoon Kim1

  • 1School of Materials Science and Engineering, Colorado State University, Fort Collins, Colorado, 80523, USA. m.herrera-alonso@colostate.edu.

Soft Matter
|April 2, 2025
PubMed

Insights

Researchers explored how particle surfaces interact with mucus for improved transmucosal drug delivery. Modifying surfaces with poly(2-methacryloyloxyethyl phosphorylcholine) and boronic acid showed pH-dependent mucin interactions, aiding mucus penetration strategies.

Area of Science:

  • Biomaterials Science
  • Surface Chemistry
  • Drug Delivery

Background:

  • Mucus barriers impede transmucosal drug delivery by trapping external particles.
  • Understanding surface-mucus interactions is crucial for enhancing particle transport.
  • Zwitterionic polymers and boronic acids offer potential for modulating mucus interactions.

Purpose of the Study:

  • To investigate the interaction of modified silica surfaces with mucin.
  • To evaluate the pH-dependent behavior of zwitterionic polymer and boronic acid grafted surfaces in mucus.
  • To provide insights for designing particles for effective mucus penetration.

Main Methods:

  • Grafting poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) brushes onto silica surfaces using surface-initiated SI-ARGET ATRP.
  • Conjugating 3-phenylboronic acid (APBA) to the PMPC-grafted surfaces.
  • Analyzing mucin adsorption and surface properties at different pH values.

Main Results:

  • PMPC-grafted surfaces exhibited no mucin adsorption across all tested pH levels.
  • Surfaces functionalized with APBA demonstrated specific interactions with sialic acid residues on mucins, particularly at lower pH.
  • These interactions suggest a pH-triggered mechanism for controlling particle-mucus adhesion.

Conclusions:

  • Zwitterionic PMPC coatings prevent non-specific mucin adhesion, while APBA provides pH-responsive binding.
  • The combination of PMPC and APBA on particle surfaces can be engineered to modulate mucus transport.
  • This study provides a foundation for developing advanced materials for targeted transmucosal drug delivery.